CRISPR Therapeutics AG Quarterly Payments to Acquire Property, Plant, and Equipment in USD from Q1 2016 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
CRISPR Therapeutics AG quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2016 to Q1 2024.
- CRISPR Therapeutics AG Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $721K, a 76.4% decline year-over-year.
- CRISPR Therapeutics AG annual Payments to Acquire Property, Plant, and Equipment for 2023 was $9.47M, a 74.5% decline from 2022.
- CRISPR Therapeutics AG annual Payments to Acquire Property, Plant, and Equipment for 2022 was $37.2M, a 54.5% decline from 2021.
- CRISPR Therapeutics AG annual Payments to Acquire Property, Plant, and Equipment for 2021 was $81.7M, a 345% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)